ESTRO 38 - Programme Book & Exhibition Guide

> TMLI-based low-toxic myeloablative conditioning regimen in haploidentical HSCT for AML C. Aristei, V. Lancellotta, A. Carotti, C. Zucchetti, S. Saldi (Italy), A. Pierini, L. Ruggeri, S. Piccinini, L. Amico, M. Iacco, A. Velardi, M.F. Martelli > Persistence of late substantial patient reported symptoms (LAPERS): A report from the EMBRACE study A.S. Vittrup (Denmark), L.U. Fokdal, R. Pötter, S.M. Bentzen, J.C. Lindegaard, A. Sturdza, B. Segedin, K. Bruheim, I.M. Jürgenliemk-Schulz, U. Mahantshetty, B. Rai, C. Haie-Meder, R. Cooper, S. Marit, F. Huang, E. Van der Steen-Banasik, E. Villafranca, R.A. Nout, K. Tanderup, K. Kirchheiner > Radiomics in Magnetic Resonance Imaging for prediction of radiotherapy outcomes in cervical cancer N. Thanamitsomboon (Thailand), N. Kosaisawe, K. Thephamongkhol, P. Dankulchai

SUNDAY 28 APRIL 2019

PV-0367

PV-0368

PV-0369

MULTIDISCIPLINARY TUMOUR BOARD Prostate cancer 14:30 - 15:45 | Ambra 5-6 Chair: V. Khoo (United Kingdom)

> yESTRO

S. Buus (Denmark) > Medical Oncologist M. Tucci (Italy) > Radiation Oncologist G. De Meerleer (Belgium) > Urologist A. Briganti (Italy) > Diagnostic radiologist G. Petralia (Italy)

NETWORKING SESSION Quiz and Young networking cocktail 16:00 - 17:00 | The Stage

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

132